(E) -Methyl 4-coumarate
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


(E) -Methyl 4-coumarate
Description:
(E) -Methyl 4-coumarate (Methyl 4-hydroxycinnamate) is a phenolic compound and derivative of Cinnamic acid (HY-N0610A) . (E) -Methyl 4-coumarate can be found in several plants, such as the leaves of Allium cepa and Morinda citrifolia L. (E) -Methyl 4-coumarate, when combined with Carnosic acid (HY-N0644), induces Apoptosis. (E) -Methyl 4-coumarate inhibits GSK3β activity and modulates inflammatory cytokine levels (increasing IL-10 and decreasing IL-4) . (E) -Methyl 4-coumarate combined with Carnosic acid exhibits anticancer effects against acute myeloid leukemia. (E) -Methyl 4-coumarate ameliorates Plasmodium berghei NK65 infection[1][2].Product Name Alternative:
Methyl trans-p-coumarateUNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
Apoptosis; GSK-3; Interleukin Related; ParasiteType:
Natural ProductsRelated Pathways:
Anti-infection; Apoptosis; Immunology/Inflammation; PI3K/Akt/mTOR; Stem Cell/WntApplications:
COVID-19-immunoregulationField of Research:
Cancer; InfectionAssay Protocol:
https://www.medchemexpress.com/e-methyl-4-coumarate.htmlPurity:
99.87Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
O=C(OC)/C=C/C1=CC=C(O)C=C1Molecular Formula:
C10H10O3Molecular Weight:
178.19Precautions:
H302, H315, H319, H335References & Citations:
[1]Trachtenberg A, et al. Synergistic Cytotoxicity of Methyl 4-Hydroxycinnamate and Carnosic Acid to Acute Myeloid Leukemia Cells via Calcium-Dependent Apoptosis Induction. Front Pharmacol. 2019 May 9;10:507.|[2]SUDI S, et al. A DERIVATIVE OF CINNAMIC ACID, METHYL-4-HYDROXYCINNAMATE MODULATES INFLAMMATORY CYTOKINE LEVELS IN MALARIA-INFECTED MICE THROUGH INHIBITION OF GSK3. Malaysian Applied Biology, 2018, 47 (3) : 153-157.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
GSK-3β; IL-10; IL-4CAS Number:
19367-38-5
